MODERN APPROACHES TO THE TREATMENT OF UROGENITAL DISORDERS IN PERIMENOPAUSAL WOMEN

Authors

  • L. V. Potapova Kharkiv National Medical University
  • I. N. Shcherbina Kharkiv National Medical University

DOI:

https://doi.org/10.11603/24116-4944.2020.2.11854

Keywords:

perimenopause, urogenital infections, urinary incontinence, dryness of the vagina, dysbiosis, estrogen deficiency states, vaginal suppositories

Abstract

The aim of the study – to increase the effectiveness of treatment of perimenopausal women with urogenital disorders by studying the effect of local application of liquid vaginal suppositories "Vaginal-panten" (Angie).

Materials and Methods. We examined 176 women with urogenital disorders in perimenopausal period, whose average age was (52.2±4.8) years. In group I – 86 (48.8 %) patients received traditional treatment. Group II included 90 (51.1 %) patients who, in order to eliminate the symptoms of bacterial vaginosis due to individual intolerance to local HRT, were prescribed “Vaginal-Panten” liquid suppositories intravaginally to restore the vaginal microbiota.

Results and Discussion. As a result of the treatment, there was a decrease in vaginal dryness and itching in 87.7 % of cases, no vaginal burning sensation in 74.4 % of cases, normalization of the clinical analysis of urine samples, a significant decrease in nocturia by 3 times, a positive cough test by 2 times and pollakiuria by 2.5 times (p˂0.05).

Conclusion. Vaginal suppositories “Vaginal-Panten” can be successfully used in the treatment of urogenital disorders in perimenopause, which is especially important for women with contraindications to the use of synthetic estrogen-containing drugs.

Author Biographies

L. V. Potapova, Kharkiv National Medical University

Doctor of Medical Sciences, Professor of the Department of Obstetrics and Gynecology No. 1 Kharkiv National Medical University

I. N. Shcherbina, Kharkiv National Medical University

Doctor of Medical Sciences, Professor of the Department of Obstetrics, Gynecology and Pediatric Gynecology, Kharkiv National Medical University

References

Alvisi, S., Gava, G., Orsili, I., Giacomelli, G., Baldassarre, M., Seracchioli, R., & Meriggiola, M.C. (2019). Vaginal health in menopausal women. Medicina (Kaunas), 55 (10), 615. DOI: 10.3390/medicina55100615.

Yermakova, Ye.I. (2019). Genitourinarnyy menopauzalnyy sindrom: diagnostika i printsipy lecheniya [Genitourinary menopausal syndrome: diagnosis and treatment principles]. Meditsinskiy sovet – Medical Council, 13, 106-111. DOI: 10.21518/2079-701X-2019-13-106-111.

Yureneva, S.V., Yermakova, Ye.I., & Glazunova, A.V. (2016). Diagnostika i terapiya genitourinarnogo menopauzalnogo sindroma u patsiyentok v peri- i postmenopauze (kratkiye klinicheskiye rekomendatsii) [Diagnosis and therapy of genitourinary menopausal syndrome in patients in peri- and postmenopausal women (brief clinical recommendations)]. Akusherstvo i ginekologiya – Obstet. Gynecol., 5, 138-144. DOI: 10.18565/aig.2016.5.138-144 [in Russian].

Hodges, A.L., Holland, A.C., Dehn, B., & Pace, D.T. (2018). Diagnosis and treatment of genitourinary syndrome of menopause. Nurs. Women's Health, 22 (5), 423-430. DOI: 10.1016/j.nwh.2018.07.005.

The North American Menopause Society. (2013). Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause, 20 (9), 888-902. DOI: 10.1097/GME.0b013e3182a122c2.

(2017). The 2017 hormone therapy position statement of the North American Menopause Society NAMS. Menopause, 24 (7), 728-753.

Yefimenko, O.O. (2020). Menopauza. Problema, shcho ne vtrachaye aktualnosti [Menopause. A problem that is not out of date: Specialist comment and updated data from the national consensus on the management of patients in menopause]. Reprodukt. endokrynol. – Reprod. Endocrinol., 51, 72-88. DOI: 10.18370/2309-4117.2020.51.72-88 [in Ukrainian].

Baber, R.J., Panay, N., & Fenton, A. (2016). 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric, 19 (2), 109-150. DOI: 10.3109/13697137.2015.1129166.

Fait, T. (2019). Menopause hormone therapy: Latest developments and clinical practice. Drugs Context, 8, 212551.

O'Neill, S., & Eden, J. (2017). The pathophysiology of menopausal symptoms. Obstet. Gynaecol. Reprod. Med., 27 (10), 303-310. DOI: 10.1016/j.ogrm.2017.07.002.

Nappi, R.E., Di Carlo, C., & Becorpi, A.M. (2020). The effect of vulvovaginal atrophy on women’s quality of life from an italian cohort of the EVES study. J. Obstet. Gynaecol., 40 (4), 512-519. DOI: 10.1080/01443615.2019.1621824.

Smetnik, V.P. (Ed.). (2012). Estrogeny: ot sinteza do klinicheskogo primeneniya: kollektivnaya monografiya [Estrogens: from synthesis to clinical use: collective monograph]. Moscow: Prakticheskaya meditsina [in Russian].

Brotman, R.M., Shardell, M.D., Gajer, P., Fadrosh, D., Chang, K., Silver, M.I., …, & Gravitt, P.E. (2018). Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause, 25 (11), 1321-1330. DOI: 10.1097/gme.0b013e3182a4690b.

Dobrokhotova, Yu.E., Ilina, I.Yu., Venediktova, M.G., Morozova, K.V., & Suvorova, V.A. (2018). Lokalnaya negormonalnaya terapiya bolnykh s genitourinarnym menopauzalnym sindromom [Local non-hormonal therapy of patients with genitourinary menopausal syndrome]. Rossiyskiy vestnik akushera-ginekologa – Russ. Bull. Obstet. Gynecol., 18 (3), 88-94 [in Russian].

Dijaković, A. (2012). Urogenital atrophy (UGA) incontinence as an estrogenic deficit result in perimenopause and postmenopause. Medica Jadertina, 42 (1-2), 51-54.

Santoro, N., Epperson, C.N., & Mathews, S.B. (2015). Menopausal symptoms and their management. Endocrinol. Metab. Clin. North Am., 44 (3), 497-515. DOI: 10.1016/j.ecl.2015.05.001.

Chernova, N.I., & Arutyunyan, E. (2018). Sovremennyye aspekty terapii patsiyentok s distrofiyey i atrofiyey intimnoy zony. Chto novogo? [Current aspects of treatment in patients with dystrophy and atrophy of the intimate area. What is new?] Rossiyskiy vestnik akushera-ginekologa – Russ. Bull. Obstet. Gynecol., 18 (3), 95-98 [in Russian].

Gradison, M. (2009). Menstrual, urogynecological and vasomotor changes in perimenopause and menopause. Handbook of women's health. Rosenfeld, J.A. Ed. 2nd edn., Ch. 11. Cambridge University Press. Retrieved from: https://doi.org/10.1017/CBO9780511642111.011.

Palacios, S., Hidalgo, M.J.C., González, S.P., Manubens, M., & Sánchez-Borrego, R. (2019). Genitourinary syndrome of menopause: Recommendations from the spanish society of obstetrics and gynecology. Progresos De Obstetricia y Ginecologia, 62 (2), 141-148. DOI: 10.20960/j.pog.00182.

Sukhikh, G.T, Smetnik, V.P., Yureneva, S.V., Ermakova, E.I., Chernukha, G.E., & Yakushevskaya, O.V. (2016). Menopauza i klimaktericheskoye sostoyaniye u zhenshchiny. Klinicheskiye rekomendatsii [Menopause and climacteric state in women. Clinical guidelines]. Retrieved from: https://medi.ru/klinicheskie-rekomendatsii/menopauza-i-klimaktericheskoe-sostoyanie-u-zhenschiny_14063.

Cagnacci, A., Xholli, A., Sclauzero, M., Venier, M., Palma, F., & Gambacciani, M. (2019). Vaginal atrophy across the menopausal age: Results from the ANGEL study. Climacteric, 22 (1), 85-89. DOI: 10.1080/13697137.2018.1529748.

Gao, M., Goodman, A., Mishra, G., & Koupil, I. (2019). Associations of birth characteristics with perimenopausal disorders: A prospective cohort study. J. Develop. Orig. Health Dis., 10 (2), 246-252.

Palacios, S., Combalia, J., Emsellem, C., Gaslain, Y., & Khorsandi, D. (2020). Therapies for the management of genitourinary syndrome of menopause. Post Reprod. Health, 26 (1), 32-42. DOI: 10.1177/2053369119866341.

Cagnacci, A., Venier, M., Xholli, A., Paglietti, C., & Caruso, S. (2020). Female sexuality and vaginal health across the menopausal age. Menopause, 27 (1), 14-19. DOI: 10.1097/GME.0000000000001427.

Sinha, A., & Ewies, A.A. (2013). Non-hormonal topical treatment of vulvovaginal atrophy: an up-todate overview. Climacteric, 16 (3), 305-312. DOI: 10.3109/13697137.2012.756466.

Hope, M.E., Farmer, L., Mcallister, K.F., & Cumming, G.P. (2010). Vaginismus in peri- and postmenopausal women: A pragmatic approach for general practitioners and gynaecologists. Menopause Int., 16 (2), 68-73. DOI: 10.1258/mi.2010.010016.

Palacios, S., Nappi, R. E., Bruyniks, N., Particco, M., & Panay, N. (2018). The european vulvovaginal epidemiological survey (EVES): Prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric, 21 (3), 286-291. DOI: 10.1080/13697137.2018.1446930.

Stika, C.S. (2010). Atrophic vaginitis. Dermatol. Ther., 23 (5), 514-522. DOI: 10.1111/j.1529-8019.2010.01354.x.

Vdovychenko, Yu.P., Yefimenko, O.O., Pedachenko, N.Yu., & Yatsyna, O.I. (2019). Dyferentsiiovani pidkhody do likuvannia henitourynarnoho syndromu v zhinok u perymenopauzi [Differentiated approach to the treatment of genitourinary syndrome in perimenopausal women]. Reprodukt. endokrynol. – Reprod. Endocrinol., 46, 8-18. Retrieved from: http://doi.org/10.18370/2309-4117.2019.50.43-46 [in Ukrainian].

Published

2021-03-04

How to Cite

Potapova, L. V., & Shcherbina, I. N. (2021). MODERN APPROACHES TO THE TREATMENT OF UROGENITAL DISORDERS IN PERIMENOPAUSAL WOMEN. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 143–148. https://doi.org/10.11603/24116-4944.2020.2.11854

Issue

Section

OBSTETRICS AND GYNECOLOGY